Albert Cha
InvestorManaging Partner at Frazier Life Sciences Β· Managing Partner at Vivo Capital
Palo Alto
FoundedAclaris Therapeutics
About
Albert Cha is a Managing Partner on Frazier's Life Sciences team, which he co-leads, and co-manages the Frazier Life Sciences Public Fund; he joined the firm in 2021 with over 25 years of experience investing in biopharmaceutical and medical device companies. He was previously a Managing Partner at Vivo Capital and earlier worked at Oracle Corporation in pharmaceutical consulting and at the Palo Alto VA Hospital as a biomedical engineer. He holds B.S. and M.S. degrees in Electrical Engineering from Stanford University and completed the Medical Scientist Training Program at UCLA School of Medicine, earning an M.D. and a Ph.D. in Neuroscience.
Invests in
BiotechMedical Devices
Experience
- Frazier Life SciencesManaging Partnercurrent2021 β present
- Ascendis PharmaChairmancurrent2021 β presentCopenhagen, Capital Region of Denmark, Denmark
- KalVista Pharmaceuticals, Inc.Board Member2016 β 2024Cambridge, Massachusetts, United States
- Vivo CapitalManaging Partner2000 β 2020
- OracleConsultant1992 β 1993
Education
- Stanford UniversityM.S., Electrical Engineering
- Stanford UniversityB.S., Electrical Engineering
- UCLAM.D./Ph.D., Neuroscience
Skills & more
+8 more
Financial ModelingManagement ConsultingProduct ManagementProduct DevelopmentM&A experiencePharmaceutical IndustryStrategic PlanningStrategyFrom Albert's professional profile.
Same school
Also attended Stanford University1,739
+ 1,733 more
Also attended UCLA394
+ 388 more
Shared employers
Investments
Board seats
Aclaris TherapeuticsAscendis Pharma A/SBiohaven PharmaceuticalsKalVista Pharmaceuticals
Per the firm's website.
Colleagues at Frazier Life Sciences
Network7
Investors connected to Albert in public investor directories β a warm-intro map.





























